News Release

View printer-friendly version
<< Back

DURECT to Present at Upcoming Conferences

CUPERTINO, Calif., Nov 01, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it will present a corporate overview and update at two upcoming life sciences conferences in New York, NY.

-- CIBC World Markets 18th Annual Healthcare Conference on Monday, November 5, 2007 at the Waldorf-Astoria Hotel at 1:20 p.m. EST.
-- Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference on Tuesday, November 6, 2007 at the New York Palace Hotel at 4:45 p.m. EST.

A live audio webcast of the presentation will be available by accessing DURECT's homepage at and clicking "Investor Relations". If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit